Copyright
©The Author(s) 2015.
World J Gastroenterol. Jun 28, 2015; 21(24): 7457-7467
Published online Jun 28, 2015. doi: 10.3748/wjg.v21.i24.7457
Published online Jun 28, 2015. doi: 10.3748/wjg.v21.i24.7457
Table 1 Clinicopathological characteristics for 100 patients with colon carcinoma
Characteristic | Number of patients | Percentage |
Sex | ||
Male | 54 | 54 |
Female | 46 | 46 |
Age (yr) | ||
< 60 | 61 | 61 |
≥ 60 | 39 | 39 |
Tumor location | ||
Right | 39 | 39 |
Transverse | 10 | 10 |
Left colon | 51 | 51 |
Depth1 | ||
< 5 mm | 72 | 72 |
≥ 5 mm | 28 | 28 |
Maximum diameter of tumor (cm) | ||
≥ 1.0 and < 5.0 | 67 | 67 |
≥ 5.0 | 33 | 33 |
Tumor differentiation | ||
Well | 19 | 19 |
Moderate | 53 | 53 |
Poor | 21 | 21 |
Unknown | 7 | 7 |
Lymph node metastasis | ||
0 | 23 | 23 |
1-4 | 32 | 32 |
≥ 5 | 45 | 45 |
Venous vessel invasion | ||
Absent | 42 | 42 |
Present | 58 | 58 |
Tumor margin | ||
Expanding | 81 | 81 |
Infiltrating | 19 | 19 |
Table 2 Effects of both integrin αvβ6 and matrix metalloproteinase-9 expression in100 cases of colon carcinoma
Table 3 Five year survival estimates for 100 patients with colon cancer
Groups | Negative/positive | n | Median survival (mo) and 95%CI | 5-yr survival rate (%) and 95%CI |
αvβ6 | Negative | 62 | 45.948 (40.575-51.320) | 0.585 (0.452-0.718) |
Positive | 38 | 36.114 (28.501-43.728) | 0.402 (0.220-0.584)1 | |
MMP-9 | Negative | 32 | 44.071 (36.812-51.330) | 0.570 (0.392-0.748) |
Positive | 68 | 41.686 (36.040-47.331) | 0.485 (0.344-0.626)2 |
- Citation: Yang GY, Guo S, Dong CY, Wang XQ, Hu BY, Liu YF, Chen YW, Niu J, Dong JH. Integrin αvβ6 sustains and promotes tumor invasive growth in colon cancer progression. World J Gastroenterol 2015; 21(24): 7457-7467
- URL: https://www.wjgnet.com/1007-9327/full/v21/i24/7457.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i24.7457